Target intelligence / Profile preview

Spire type actin nucleation factor 1 (SPIRE1)

Target
SPIRE1
Molecular classification
Actin nucleation factor, WH2 (Wiskott-Aldrich homology 2) domain-containing protein, Cytoskeletal regulatory protein
01

Overview

Spire type actin nucleation factor 1 (SPIRE1) is a highly conserved actin-regulating protein characterized by multiple functional domains including an N-terminal KIND domain (binding formin proteins), four central WH2 domains (actin binding and nucleation), a globular tail domain-binding motif (links to myosin V), and a C-terminal zinc finger-like FYVE domain (membrane association). SPIRE1 nucleates actin filaments and plays a key role in cytoskeletal organization, intracellular vesicle transport, asymmetric cell division (notably in female germ cell meiosis), and the assembly of nuclear actin filaments during DNA damage repair. Beyond its cytoskeletal functions, SPIRE1 acts as a restriction factor in antiviral immunity by promoting IRF3-dependent signaling downstream of viral RNA sensing, thereby constraining the replication and spread of various viruses. While potentially relevant in the context of infectious disease, SPIRE1 is not currently considered a direct therapeutic target, and no approved drugs are known to interact with it.

Other names
Protein spire homolog 1KIAA1135SPIR1Spir-1spire actin nucleation factor 1spire family actin nucleation factor 1spire homolog 1
02

Biological functions

Actin nucleation and filament assemblyRegulation of actin cytoskeleton and intracellular vesicle transportSpindle positioning and asymmetric cell division during meiosisAssembly of nuclear actin filaments in response to DNA damageActivation of innate immune signaling, including IRF3 phosphorylation downstream of MAVS in response to viral infection
03

Disease associations

Viral infection/host antiviral response (restriction factor for viruses such as vaccinia virus and Zika virus)Smallpox (reported association)Familial hypercholesterolemia (reported association)

Beyond the preview

Go deeper on Spire type actin nucleation factor 1 (SPIRE1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spire type actin nucleation factor 1 (SPIRE1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call